Isolation and characterization of the new genes isolated from three diseases presenting with severe psychomotor retardation.
Isolation and characterization of the new genes isolated from three diseases presenting with severe psychomotor retardation.
批准号:
15390332
负责人:
WAKAMATSU Nobuaki
金额:
$9.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
1.本研究通过FISH、Southern杂交和核苷酸序列分析,在6 q16/12 p12易位、癫痫和严重精神发育迟滞患者的12 p12断裂点上发现了一个新基因PLEKHA 5。在6 q16断裂点没有发现基因。为了研究该基因的作用,我们将Plekha 5特异性siRNA转染到小鼠Neuro 2a细胞中。当用20 μM视黄酸处理时,转染的细胞表达约40%的Plekha 5 mRNA,并且与经历模拟转染(仅载体)的细胞相比,显示出有限的神经突延伸。这一发现表明PLEKHA 5可能是这种疾病的致病基因。Plekha 5定位于细胞质。亲和纯化的PLEKHA 5显示130 kDa的大小。从一个严重精神发育迟滞家系的男性患者中分离出致病基因,并对该家系的11名成员进行了连锁分析。这11人中有3人是病人。最大 关于我们 在Xq 27的DXS 1205处获得lod评分,1.10。对患者DNA中Xq 27-ter的15个候选基因进行核苷酸序列分析,均未发现明显的突变.从一个表现为快速脑萎缩和严重精神发育迟滞的家系中分离致病基因,我们对该家系的10名成员进行了连锁分析。这10人中有4人是病人。在2 q35 -36的D2 S163和D2 S2344之间获得最大lod得分,4.75。对16个候选基因进行核苷酸序列分析,发现SLC 19 A3中存在E320 Q错义突变。患者为突变纯合子,其父母为杂合子。我们构建了由CMV启动子驱动的SLCJ 9A 3(E320 Q)表达载体pC 1-SLC 19 A3(E320 Q),并将其转染HEK 293细胞后检测了硫胺素和生物素的转运活性。然而,转运蛋白活性没有显著降低。我们现在正在生产表达Slc 193(E320 Q)的转基因小鼠,以进一步研究这种突变的影响。少
英文摘要
1. Isolation of the causal gene from the patient presenting with reciprocal 6q16/12p12 translocation, epilepsy and severe psychomotor retardation.We identified a new gene, PLEKHA5, at the breaking point of the 12p12 by FISH, Southern blot and nucleotide sequencing analyses. There was no gene located at the 6q16 breaking point. To examine the role of this gene, we transfected Plekha5-speciflc siRNA into mouse Neuro2a cells. Transfected cells express about 40% of Plekha5 mRNA and showed limited extension of the neurites compared to cells undergoing Mock transfection (vector only) when treated with 20 μM retinoic acid. This finding suggests that PLEKHA5 is likely a causal gene of this disease. Plekha5 localized at the cytoplasm. Affinity purified PLEKHA5 showed a size of 130 kDa.2. Isolation of the causal gene from male patients in a family presenting with severe psychomotor retardation.We performed linkage analysis in 11 members of the family. Three of these eleven were patients. Maximal … More lod score, 1.10, was obtained at DXS1205 of Xq27. Nucleotide sequencing analysis was performed for 15 candidate genes at Xq27-ter from the patients' DNA, but there were no apparent mutations.3. Isolation of the causal gene from patients in a family presenting with rapid brain atrophy and severe psychomotor retardation.We performed linkage analysis in 10 members of the family. Four of these ten were patients. Maximal lod score, 4.75 was obtained between D2S163 and D2S2344 at 2q35-36. Nucleotide sequence analysis was performed for 16 candidate genes and an E320Q missense mutation was found in SLC19A3. The patients were homozygous for the mutation and their parents were heterozygous. We constructed an expression vector pC1-SLC19A3 (E320Q), that expressed SLCJ9A3 (E320Q) driven by a CMV promoter and examined the transporter activity of thiamine and biotin after transfection of this vector into HEK293 cells. However, there was no remarkable reduction of transporter activity. We are now producing transgenic mouse expressing Slc193 (E320Q) to further investigate the effects of this mutation. Less
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transtplanted into nude mouse oral cavity.
培养的人口腔鳞状细胞癌中血管内皮生长因子-C和-A的表达水平分别与移植到裸鼠口腔后的淋巴转移和血管生成相关。
DOI:
--
发表时间:
2006
期刊:
Oncology Reports 15-4
影响因子:
--
作者:
[Nakazato T, et al.]
通讯作者:
et al.
MECP2遺伝子異常を伴うRett症候群の臨床症状について.
与 MECP2 基因异常相关的 Rett 综合征的临床症状。
DOI:
--
发表时间:
2005
期刊:
脳と発達 37・1
影响因子:
--
作者:
[三浦清邦, 他]
通讯作者:
他
Two cases of partial trisomy 21 (pter-q22. 1) without the major features of Down syndrome.
两例部分21三体(pter-q22.1),不具有唐氏综合症的主要特征。
DOI:
--
发表时间:
2006
期刊:
Am J Med Genet 140A
影响因子:
--
作者:
[Kondo Y, Mizuno S, Ohara K, Nakamura T, Yamada K, Yamamori S, Hayakawa C, Ishii T, Yamada Y, Wakamatsu N]
通讯作者:
Wakamatsu N
Comparison of the analyses to diagnose the carrier of the mutation in a Lesch-Nyhan family.
Lesch-Nyhan 家族中突变携带者诊断分析的比较。
DOI:
--
发表时间:
2004
期刊:
Japanese Journal of Pediatrics 57-5
影响因子:
--
作者:
[Igarashi N, et al.]
通讯作者:
et al.
Lesch-Nyhan症候群1家系の保因者診断における各種解析法の比較検討.
Lesch-Nyhan 综合征家系携带者诊断的多种分析方法的比较研究。
DOI:
--
发表时间:
2004
期刊:
小児科臨床 57・5
影响因子:
--
作者:
[五十嵐登, 他]
通讯作者:
他
共 33 条
The pathogenic mechanisms of severe intellectual disabiIity caused by PLEKHA5 or SLC19A3 mutations studied using mouse models of the diseases.
-
批准号:21390319
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2009
-
负责人:WAKAMATSU Nobuaki
-
依托单位:
Molecular and biochemical analysis of the severe mental retardation caused by PLEKHA5 or SLC19A3 mutations.
-
批准号:18390305
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.39万
-
财政年份:2006
-
负责人:WAKAMATSU Nobuaki
-
依托单位:
Identification and characterization of genes in patients with severe mental retardation caused by autosomal dominant trait.
-
批准号:13670158
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:WAKAMATSU Nobuaki
-
依托单位:
Molecular genetic analysis and trial of making mouse model of α-mannosidosis.
-
批准号:11670630
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:WAKAMATSU Nobuaki
-
依托单位:
Molecular genetic analysis and establishment of the genetic diagnosis of autosomal recessive malignant limb-girdle muscular dystrophy.
-
批准号:09670658
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:WAKAMATSU Nobuaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位: